AlphaGenome 2 opens research API access, not clinical diagnosis
Google announced cell-type-specific DNA variant predictions on November 11; commercial research remains in private preview.
The announcement says non-commercial API access began that day; exact timing and time zone are unknown. Antigravity Skills are still forthcoming.
Official documentation lists free non-commercial API use with demand-dependent query rates; commercial pricing is unknown. Access uses the API, Python and Colab tutorials; a standalone mobile app is unconfirmed. Reviewed technical documentation is English; Traditional Chinese support is unknown.
The FAQ prohibits using outputs to train machine-learning models or make clinical decisions. Not tested by this site; predictions are not validated diagnoses.
Documentation: https://www.alphagenomedocs.com/
Restrictions: https://www.alphagenomedocs.com/faqs.html
Official documentation lists free non-commercial API use with demand-dependent query rates; commercial pricing is unknown. Access uses the API, Python and Colab tutorials; a standalone mobile app is unconfirmed. Reviewed technical documentation is English; Traditional Chinese support is unknown.
The FAQ prohibits using outputs to train machine-learning models or make clinical decisions. Not tested by this site; predictions are not validated diagnoses.
Documentation: https://www.alphagenomedocs.com/
Restrictions: https://www.alphagenomedocs.com/faqs.html
Usage conditions
- Hong Kong
- API eligibility for Hong Kong accounts is unconfirmed; not tested.
- Macau
- API eligibility for Macau accounts is unconfirmed; not tested.
- Taiwan
- API eligibility for Taiwan accounts is unconfirmed; not tested.
Official source: AlphaGenome 2: Deciphering how cells read DNA to better understand disease